Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

60
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
60
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

103
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
103
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

64
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
64
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

385
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
385
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

129
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
129
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

60
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
60

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anatomical, physiological, and luminal adaptations occurring in an ileoanal pouch: opportunities for improving outcomes.

Inflammatory bowel diseases·2026
Same author

Phylogenomic analyses of the Austral podocarps (Podocarpus: Podocarpaceae) support hybrid ancestry of a New Zealand species.

Molecular phylogenetics and evolution·2026
Same author

Interleukin-10 Autoantibodies and HLA-DRB1*01:03 in Inflammatory Bowel Disease.

The New England journal of medicine·2026
Same author

Systematic Review and Meta-analysis of Anti-interferon Auto-antibodies in Infectious Diseases.

Journal of clinical immunology·2026
Same author

The introduction of an intestinal ultrasound service is associated with significantly reduced endoscopy usage in an inflammatory bowel disease service-the SCOPELESS study.

Journal of Crohn's & colitis·2026
Same author

The UCEIS and UC-100 score were responsive endoscopic and global indices in a phase 2 trial of ulcerative colitis.

Crohn's & colitis 360·2026
Same journal

Update on the Management of Pregnant Patients With Inflammatory Bowel Disease.

Gastroenterology & hepatology·2026
Same journal

Management of Granulomatous Hepatitis.

Gastroenterology & hepatology·2026
Same journal

Update on Pregnancy in Inflammatory Bowel Disease.

Gastroenterology & hepatology·2026
Same journal

Strategies for Improving Hepatocellular Carcinoma Surveillance Rates.

Gastroenterology & hepatology·2026
Same journal

Managing the Diagnostic and Therapeutic Challenges of Irritable Bowel Syndrome.

Gastroenterology & hepatology·2026
Same journal

Raising the Bar on Risk Reduction in Post-ERCP Pancreatitis Prevention.

Gastroenterology & hepatology·2026
See all related articles

Related Experiment Video

Updated: May 29, 2025

Author Spotlight: Developing a Rat Model for Pouchitis Research and Treatment
04:05

Author Spotlight: Developing a Rat Model for Pouchitis Research and Treatment

Published on: May 31, 2024

293

Navigating Chronic Pouchitis: Pathogenesis, Diagnosis, and Management.

Robert Hill1,2, Simon Travis1,3, Zaid Ardalan4,5

  • 1Translational Gastroenterology Unit, University of Oxford, Oxford, United Kingdom.

Gastroenterology & Hepatology
|February 3, 2025
PubMed
Summary
This summary is machine-generated.

Chronic pouchitis, affecting up to 20% of patients, requires tailored management based on antibiotic response. This review details its causes, diagnosis, and treatment strategies for better patient outcomes.

Keywords:
Ulcerative colitisantibiotic-refractory pouchitispathogenesispouchitisvedolizumab

More Related Videos

A Mouse Model for Pathogen-induced Chronic Inflammation at Local and Systemic Sites
09:52

A Mouse Model for Pathogen-induced Chronic Inflammation at Local and Systemic Sites

Published on: August 8, 2014

17.5K
Chronic Salmonella Infection Induced Intestinal Fibrosis
08:40

Chronic Salmonella Infection Induced Intestinal Fibrosis

Published on: September 22, 2019

7.0K

Related Experiment Videos

Last Updated: May 29, 2025

Author Spotlight: Developing a Rat Model for Pouchitis Research and Treatment
04:05

Author Spotlight: Developing a Rat Model for Pouchitis Research and Treatment

Published on: May 31, 2024

293
A Mouse Model for Pathogen-induced Chronic Inflammation at Local and Systemic Sites
09:52

A Mouse Model for Pathogen-induced Chronic Inflammation at Local and Systemic Sites

Published on: August 8, 2014

17.5K
Chronic Salmonella Infection Induced Intestinal Fibrosis
08:40

Chronic Salmonella Infection Induced Intestinal Fibrosis

Published on: September 22, 2019

7.0K

Area of Science:

  • Gastroenterology
  • Inflammatory Bowel Disease
  • Surgical Outcomes

Background:

  • Chronic pouchitis affects 13-17% of ulcerative colitis patients with ileal pouch-anal anastomosis, and 20% with prior acute pouchitis.
  • It is categorized by antibiotic responsiveness into chronic antibiotic-dependent and chronic antibiotic-refractory pouchitis.
  • Pathogenesis involves microbial and immune-mediated processes, with antibiotic resistance being a key factor.

Purpose of the Study:

  • To review the pathogenesis, diagnosis, and management of chronic pouchitis.
  • To highlight the importance of a diagnostic index combining clinical, endoscopic, and histologic data.
  • To outline current and advanced therapeutic strategies based on pouchitis classification.

Main Methods:

  • Review of existing literature on chronic pouchitis.
  • Analysis of diagnostic criteria and classification systems.
  • Evaluation of treatment efficacy for different pouchitis subtypes.

Main Results:

  • Chronic pouchitis has diverse etiologies, ranging from microbial imbalances to immune dysregulation.
  • A comprehensive diagnostic index is crucial for accurate assessment and research.
  • Management strategies differ significantly between antibiotic-dependent and antibiotic-refractory forms.

Conclusions:

  • Chronic antibiotic-dependent pouchitis often responds to microbiota- or immune-targeted therapies.
  • Chronic antibiotic-refractory pouchitis primarily requires immune-directed therapy, with vedolizumab as a recommended first-line agent.
  • Advanced therapies may have reduced efficacy due to pre-colectomy factors, necessitating further research.